Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02562404 · ClinicalTrials.gov registry record
Vagus Nerve Injury Post Radiofrequency Catheter Ablation for Atrial Fibrillation
A clinical trial, sponsored by Intermountain Health Care.
- Completed
- Registry status
- 100
- Enrollment target
NCT02562404 is a clinical trial that has completed, run by Intermountain Health Care. The registered enrollment target is 100 participants.
The verdict
NCT02562404 has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This study is an observational study designed to determine the extent of gastrointestinal (GI) post-procedure complications after Radiofrequency Catheter Ablation (RFCA) for atrial fibrillation (AF). This exploratory study will evaluate patient symptoms prior to the RFCA procedure, at 1 month post RFCA procedure, and at 3 months post RFCA procedure, through the administration of a questionnaire. The purpose of this study is to determine if vagus nerve injury resulting from RFCA for AF increases the risk of post-procedure GI complications that may present as temporary or permanent symptoms.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02562404
The ClinicalTrials.gov registry entry for NCT02562404 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02562404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02562404 about?
NCT02562404 is a clinical study titled "Vagus Nerve Injury Post Radiofrequency Catheter Ablation for Atrial Fibrillation". This study is an observational study designed to determine the extent of gastrointestinal (GI) post-procedure complications after Radiofrequency Catheter Ablation (RFCA) for atrial fibrillation (AF). This exploratory study will evaluate patient symptoms prior to the RFCA procedure, at 1 month post R...
What is the current status of trial NCT02562404?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2015-04. Estimated completion is 2016-12.
Who is sponsoring clinical trial NCT02562404?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.